USPTO serial 87849391
LEUKOTAC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 4, 2020
- Examiner
- GARTNER, JOHN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LEUKOTAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle P. Ciotola
Michelle P. Ciotola CANTOR COLBURN LLP20 CHURCH STREETFLOOR 22HARTFORD, CT 06103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for immuno-oncology and autoimmune disease; pharmaceutical preparations, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; veterinary preparations for immuno-oncology and autoimmune disease; veterinary preparations, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; biotechnological preparations for medical and veterinary use, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases | ACTIVE | — |
| 042 | Research and consultancy in the field of biotechnology; research and development in the field of biotechnology; scientific and technical consultation, namely, engineering evaluations and appraisals in the fields of science and technology; scientific and technology research in the field of immuno-oncology and autoimmune disease; laboratory research and analysis services in the field of immuno-oncology and autoimmune disease; scientific chemistry, biology and biotechnology laboratories; scientific laboratory services; laboratory testing, research and development of new products for others; conducting clinical trials for others in the field of medicines, molecules and medical devices; medical laboratory analysis services relating to the treatment of persons; medical laboratory services, including sample analysis; medical laboratory analysis services | ACTIVE | — |
| 044 | Medical services; pharmaceutical advice | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ELSALYS BIOTECH
- Other trademarks owned by ELSALYS BIOTECH
- Other trademarks owned by ELSALYS BIOTECH
- Other trademarks owned by MEDIOLANUM FARMACEUTICI S.P.A.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LEUKOTAC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 24, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 4, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 19, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 19, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 14, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 10, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 3, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 3, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 3, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 26, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 24, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 24, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 24, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 24, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 24, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 28, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 28, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 28, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 28, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 28, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 28, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 17, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 17, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 14, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 11, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 29, 2018 | NWAP | NEW APPLICATION ENTERED | — |